Pharma Links

http://pharma.about.com/cs/bg.htm
http://pharma.about.com/mpboards.htm
http://pharma.about.com/forum/
http://pharma.about.com/
http://pharma.about.com/od/FDA/a/2012-Renewal-Of-The-Prescription-Drug-User-Fee-Act-Pdufa.htm
http://pharma.about.com/od/FDA/a/New-Drugs-Approved-By-The-Fda-In-2011_4.htm
http://pharma.about.com/od/FDA/a/Viibryd-First-New-Antidepressant-In-A-Decade.htm
http://pharma.about.com/od/FDA/a/Diabetes-Drug-Approval-Process.htm
http://pharma.about.com/od/FDA/a/New-Drugs-Approved-By-The-Fda-In-2011_3.htm
http://pharma.about.com/od/FDA/a/Encouraging-Rare-Diseases-Products-Development.htm
http://pharma.about.com/od/FDA/a/New-Drugs-Approved-By-The-Fda-In-2011.htm
http://pharma.about.com/od/FDA/a/New-Drugs-Approved-By-The-Fda-In-2011_2.htm
http://pharma.about.com/od/FDA/Fda-Approval.htm
http://pharma.about.com/od/C/C.htm
http://pharma.about.com/od/C/g/Current-Good-Manufacturing-Practices-Cgmps.htm
http://pharma.about.com/od/C/g/Comparative-Effectiveness-Research-Cer.htm
http://pharma.about.com/od/Over-the-Counter-Medicine/Over-The-Counter-Medicine.htm
http://pharma.about.com/od/Over-the-Counter-Medicine/a/Behind-The-Counter-Drugs.htm
http://pharma.about.com/od/Over-the-Counter-Medicine/a/Over-The-Counter-Drugs-Theres-A-Recipe-For-That.htm
http://pharma.about.com/od/N/g/New-Drug-Application-Nda.htm
http://pharma.about.com/od/N/N.htm
http://pharma.about.com/od/A/A.htm
http://pharma.about.com/od/A/g/Abbreviated-New-Drug-Application.htm
http://pharma.about.com/od/A/g/Authorized-Generic-Definition.htm
http://pharma.about.com/od/A/g/Adverse-Event-Reporting-Aer.htm
http://pharma.about.com/od/M/g/Medically-Necessary.htm
http://pharma.about.com/od/M/M.htm
http://pharma.about.com/od/Glossary/Pharma-A-to-Z.htm
http://pharma.about.com/od/Insurance-and-Medicare/a/Medicare-Waste-And-Monitoring.htm
http://pharma.about.com/od/Insurance-and-Medicare/a/Government-Health-Plans-And-The-Pharmaceutical-Industry.htm
http://pharma.about.com/od/Insurance-and-Medicare/i/Negotiating-Part-D_2.htm
http://pharma.about.com/od/Insurance-and-Medicare/i/Negotiating-Part-D.htm
http://pharma.about.com/od/Insurance-and-Medicare/Insurance-And-Medicare-Medicaid.htm
http://pharma.about.com/od/Clinical-Trials/a/Rating-Clinical-Trials.htm
http://pharma.about.com/od/Clinical-Trials/a/Opportunities-And-Challenges-Of-Pediatric-Clinical-Drug-Trials.htm
http://pharma.about.com/od/Clinical-Trials/a/Clinical-Trials-Training-Opportunities.htm
http://pharma.about.com/od/Clinical-Trials/Clinical_Trials.htm
http://pharma.about.com/od/Philanthropy/a/Pharma-Partners-Pledge-1-4-Billion-Annually-To-Eradicate-Tropic.htm
http://pharma.about.com/od/Philanthropy/a/Pharmas-And-Corporate-Philanthropy.htm
http://pharma.about.com/od/Philanthropy/Philanthropy.htm
http://pharma.about.com/od/
http://pharma.about.com/od/Manufacturing-and-Technology/a/Pharmas-And-Fda-Inspections.htm
http://pharma.about.com/od/Manufacturing-and-Technology/a/Going-Green-Is-Good-For-Business.htm
http://pharma.about.com/od/Manufacturing-and-Technology/i/Drug-Shortages.htm
http://pharma.about.com/od/Manufacturing-and-Technology/i/Drug-Shortages_2.htm
http://pharma.about.com/od/Manufacturing-and-Technology/Manufacturing-And-Technology.htm
http://pharma.about.com/od/Research-and-Development/a/Pharmas-Still-Finding-New-Uses-For-Botulinum-Toxin.htm
http://pharma.about.com/od/Research-and-Development/a/What-Are-The-Elements-Of-A-Research-Article.htm
http://pharma.about.com/od/Research-and-Development/a/Addressing-The-Antibiotics-Crisis.htm
http://pharma.about.com/od/Research-and-Development/a/Who-Funds-Biomedical-Research.htm
http://pharma.about.com/od/Research-and-Development/a/diabetespipeline.htm
http://pharma.about.com/od/Research-and-Development/a/Alternatives-To-Warfarin-For-Stroke-Prevention.htm
http://pharma.about.com/od/Research-and-Development/Research-And-Development.htm
http://pharma.about.com/od/Research-and-Development/u/Innovations.htm
http://pharma.about.com/od/Government_IP/a/Should-Pediatricians-Fire-Families-For-Refusing-Vaccines.htm
http://pharma.about.com/od/Government_IP/a/Ip-Laws-And-Pharma.htm
http://pharma.about.com/od/Government_IP/a/Pharmas-And-The-Stop-Internet-Piracy-Act.htm
http://pharma.about.com/od/Government_IP/a/Health-Care-Reform-Implementation-Schedule-For-Pharmas.htm
http://pharma.about.com/od/Government_IP/a/How-Are-Pharma-Companies-Preparing-For-Proposed-Changes-To-U-S-Health-Care.htm
http://pharma.about.com/od/Government_IP/a/The-Patent-Reform-Act-Of-2011-And-The-Pharmaceutical-Industry.htm
http://pharma.about.com/od/Government_IP/Government-And-Intellectual-Property.htm
http://pharma.about.com/od/Government_IP/i/Preventing-Counterfeit-Drug-Trade_2.htm
http://pharma.about.com/od/Government_IP/i/Gene-Patents_2.htm
http://pharma.about.com/od/Government_IP/i/Preventing-Counterfeit-Drug-Trade.htm
http://pharma.about.com/od/Government_IP/i/Gene-Patents.htm
http://pharma.about.com/od/Government_IP/u/Regulations.htm
http://pharma.about.com/od/BigPharma/Big-Pharma.htm
http://pharma.about.com/od/BigPharma/a/Wikileaks-Cables-Show-Diplomats-Aggressively-Promote-Pharmaceutical-Industry.htm
http://pharma.about.com/od/BigPharma/a/Side-Effects-Associated-With-Gardasil.htm
http://pharma.about.com/od/BigPharma/tp/Big-Pharmas-Merger-Mania.htm
http://pharma.about.com/od/BigPharma/tp/Top-U-S-Pharmas.htm
http://pharma.about.com/od/BigPharma/tp/Big-Ten-Branded-Drug-Blockbusters-Of-2010.htm
http://pharma.about.com/od/BigPharma/p/Glaxosmithkline-Gsk.htm
http://pharma.about.com/od/BigPharma/p/Johnson-And-Johnson-Jandj.htm
http://pharma.about.com/od/BigPharma/p/Pfizer.htm
http://pharma.about.com/od/BigPharma/u/Issues.htm
http://pharma.about.com/od/P/g/Protein-Misfolding-Diseases.htm
http://pharma.about.com/od/P/P.htm
http://pharma.about.com/od/Sales_and_Marketing/Sales-And-Marketing.htm
http://pharma.about.com/od/Sales_and_Marketing/a/What-Strategies-Can-A-Pharma-Marketer-Use-To-Reach-Doctors.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Pharmaceutical-Companies-Test-Opportunities-In-Russia.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Study-Younger-Physicians-More-Skeptical-Of-Vaccines.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Physician-Attitudes-Toward-Industry-Marketing.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Anti-Obesity-Drug-Market-Trends.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Data-Mining-Doctors-Prescribing-History.htm
http://pharma.about.com/od/Sales_and_Marketing/a/The-China-Pharmaceutical-Market.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Anti-Obesity-Drug-Market-Trends_2.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Pharmaceutical-Companies-Flock-To-Brazil.htm
http://pharma.about.com/od/Sales_and_Marketing/a/The-Most-Prescribed-Medications-By-Drug-Class.htm
http://pharma.about.com/od/Sales_and_Marketing/tp/PharmaNewsSites.01.htm
http://pharma.about.com/od/Sales_and_Marketing/tp/Top-Multiple-Sclerosis-Drugs.htm
http://pharma.about.com/od/Sales_and_Marketing/tp/PharmaNewsSites.htm
http://pharma.about.com/od/Sales_and_Marketing/tp/Top-Branded-Drug-Sales-For-2011.htm
http://pharma.about.com/od/Sales_and_Marketing/u/Markets.htm
http://pharma.about.com/od/B/B.htm
http://pharma.about.com/od/B/g/Black-Box-Warning.htm
http://pharma.about.com/od/B/g/Biogeneric-Drugs.htm
http://pharma.about.com/od/B/g/Biobetter.htm
http://pharma.about.com/od/B/g/Biologic-License-Application-Bla.htm
http://pharma.about.com/od/B/g/Background-Contamination.htm
http://pharma.about.com/od/Generics/a/Generic-Drug-Launches.htm
http://pharma.about.com/od/Generics/a/Generic-Drug-Pipeline.htm
http://pharma.about.com/od/Generics/Generics-And-Biosimilars.htm
http://pharma.about.com/forums/
http://pharma.about.com/b/a/2012_05_14.htm
http://pharma.about.com/b/a/200603.htm
http://pharma.about.com/b/a/2012_05_12.htm
http://pharma.about.com/b/a/2011_04_17.htm
http://pharma.about.com/b/a/2011_10_10.htm
http://pharma.about.com/b/a/201105.htm
http://pharma.about.com/b/a/2006_03_29.htm
http://pharma.about.com/b/a/2012_01_14.htm
http://pharma.about.com/b/a/201201.htm
http://pharma.about.com/b/a/2011_11_20.htm
http://pharma.about.com/b/a/201102.htm
http://pharma.about.com/b/a/2011_01_23.htm
http://pharma.about.com/b/a/2012_04_09.htm
http://pharma.about.com/b/a/2011_06_21.htm
http://pharma.about.com/b/a/2010_12_17.htm
http://pharma.about.com/b/a/201011.htm
http://pharma.about.com/b/a/201108.htm
http://pharma.about.com/b/a/2011_05_25.htm
http://pharma.about.com/b/a/2010_12_29.htm
http://pharma.about.com/b/a/2011_05_05.htm
http://pharma.about.com/b/a/2011_10_31.htm
http://pharma.about.com/b/a/2012_01_13.htm
http://pharma.about.com/b/a/2012_01_28.htm
http://pharma.about.com/b/a/2010_12_10.htm
http://pharma.about.com/b/a/2012_04_23.htm
http://pharma.about.com/b/a/2012_02_08.htm
http://pharma.about.com/b/a/2011_06_27.htm
http://pharma.about.com/b/a/2011_09_12.htm
http://pharma.about.com/b/a/2010_12_06.htm
http://pharma.about.com/b/a/2012_02_22.htm
http://pharma.about.com/b/a/2011_10_24.htm
http://pharma.about.com/b/a/201111.htm
http://pharma.about.com/b/a/2011_04_28.htm
http://pharma.about.com/b/a/2011_09_30.htm
http://pharma.about.com/b/a/201110.htm
http://pharma.about.com/b/a/2011_11_30.htm
http://pharma.about.com/b/a/201010.htm
http://pharma.about.com/b/a/2011_01_14.htm
http://pharma.about.com/b/a/2012_05_01.htm
http://pharma.about.com/b/a/2011_09_16.htm
http://pharma.about.com/b/a/2011_10_26.htm
http://pharma.about.com/b/a/2011_08_09.htm
http://pharma.about.com/b/a/2011_09_26.htm
http://pharma.about.com/b/a/2011_12_21.htm
http://pharma.about.com/b/a/2012_03_11.htm
http://pharma.about.com/b/a/2011_02_28.htm
http://pharma.about.com/b/a/201202.htm
http://pharma.about.com/b/a/2012_05_02.htm
http://pharma.about.com/b/a/2011_12_17.htm
http://pharma.about.com/b/a/2011_11_22.htm
http://pharma.about.com/b/a/2012_01_11.htm
http://pharma.about.com/b/a/2010_12_04.htm
http://pharma.about.com/b/a/2012_04_29.htm
http://pharma.about.com/b/a/2010_12_16.htm
http://pharma.about.com/b/a/2012_01_22.htm
http://pharma.about.com/b/a/2011_06_14.htm
http://pharma.about.com/b/a/2012_04_24.htm
http://pharma.about.com/b/a/2012_03_18.htm
http://pharma.about.com/b/a/2012_03_20.htm
http://pharma.about.com/b/a/2011_10_17.htm
http://pharma.about.com/b/a/2012_02_29.htm
http://pharma.about.com/b/a/2012_04_06.htm
http://pharma.about.com/b/a/2011_06_13.htm
http://pharma.about.com/b/a/2011_08_13.htm
http://pharma.about.com/b/a/2010_10_14.htm
http://pharma.about.com/b/a/2011_01_25.htm
http://pharma.about.com/b/a/2012_04_30.htm
http://pharma.about.com/b/a/2011_08_07.htm
http://pharma.about.com/b/a/2011_08_17.htm
http://pharma.about.com/b/a/2011_09_13.htm
http://pharma.about.com/b/a/2011_03_07.htm
http://pharma.about.com/b/a/2012_01_09.htm
http://pharma.about.com/b/a/201112.htm
http://pharma.about.com/b/a/2011_11_28.htm
http://pharma.about.com/b/a/2011_12_31.htm
http://pharma.about.com/b/a/201205.htm
http://pharma.about.com/b/a/2011_08_06.htm
http://pharma.about.com/b/a/2011_05_11.htm
http://pharma.about.com/b/a/2010_12_13.htm
http://pharma.about.com/b/a/2010_11_19.htm
http://pharma.about.com/b/a/2012_02_16.htm
http://pharma.about.com/b/a/201106.htm
http://pharma.about.com/b/a/2011_07_07.htm
http://pharma.about.com/b/a/2011_06_07.htm
http://pharma.about.com/b/a/2012_03_26.htm
http://pharma.about.com/b/a/2011_04_11.htm
http://pharma.about.com/b/a/2011_11_07.htm
http://pharma.about.com/b/a/201109.htm
http://pharma.about.com/b/a/2011_08_29.htm
http://pharma.about.com/b/a/201103.htm
http://pharma.about.com/b/a/2010_12_20.htm
http://pharma.about.com/b/a/2012_04_02.htm
http://pharma.about.com/b/a/201203.htm
http://pharma.about.com/b/a/201012.htm
http://pharma.about.com/b/a/2011_04_30.htm
http://pharma.about.com/b/a/2011_08_01.htm
http://pharma.about.com/b/a/2011_01_08.htm
http://pharma.about.com/b/a/201101.htm
http://pharma.about.com/b/a/2011_12_26.htm
http://pharma.about.com/b/a/201104.htm
http://pharma.about.com/b/a/2011_05_02.htm
http://pharma.about.com/b/a/201107.htm
http://pharma.about.com/b/a/2012_01_10.htm
http://pharma.about.com/b/a/2011_02_11.htm
http://pharma.about.com/b/a/201204.htm
http://pharma.about.com/b/a/2011_09_10.htm
http://pharma.about.com/b/a/2012_05_03.htm
http://pharma.about.com/b/a/2011_03_27.htm
http://pharma.about.com/b/a/2011_03_25.htm
http://pharma.about.com/b/a/2011_08_28.htm
http://pharma.about.com/b/a/2012_04_16.htm
http://pharma.about.com/b/s.htm
http://pharma.about.com/b/archives.htm
http://pharma.about.com/b/
http://pharma.about.com/b/2011/02/11/senators-propose-early-warning-of-drug-shortages.htm
http://pharma.about.com/b/2011/02/28/fujifilm-and-samsung-stake-claim-on-biologics-future.htm
http://pharma.about.com/b/2011/05/02/long-push-for-new-hepatitis-c-drugs-bears-fruit.htm
http://pharma.about.com/b/2011/05/25/74-percent-and-growing-most-prescriptions-now-written-for-generic-drugs.htm
http://pharma.about.com/b/2011/05/11/check-up-on-insulin-pill-development.htm
http://pharma.about.com/b/2011/05/01/exhibit-hall-hijinks.htm
http://pharma.about.com/b/2011/08/17/industry-grows-restless-waiting-for-fdas-social-media-guidance.htm
http://pharma.about.com/b/2011/08/28/canadian-pharmacy-us-seniors-groups-seek-alternative-to-blanket-ban-on-canadian-online-drug-advertising.htm
http://pharma.about.com/b/2011/08/13/fda-approves-complera-a-daily-pill-for-hiv.htm
http://pharma.about.com/b/2011/08/01/johnson-johnson-to-phase-in-lower-dosing-of-tylenol-products.htm
http://pharma.about.com/b/2011/08/09/fda-to-address-drug-shortages.htm
http://pharma.about.com/b/2011/08/06/pharma-exec-industry-consolidation-hurts-drug-research.htm
http://pharma.about.com/b/2011/08/29/fda-lower-maximum-daily-dose-of-celexa-to-protect-heart.htm
http://pharma.about.com/b/2011/08/07/glaxosmithklines-iraq-deal.htm
http://pharma.about.com/b/2011/11/20/fda-revokes-approval-of-avastin-for-breast-cancer.htm
http://pharma.about.com/b/2011/11/28/defense-department-issues-rfps-for-antibiotic-alternatives.htm
http://pharma.about.com/b/2011/11/01/study-biomedical-research-papers-have-too-many-innapropriate-authors.htm
http://pharma.about.com/b/2011/11/30/gop-proposes-no-more-medicare-subsidies-for-millionaires.htm
http://pharma.about.com/b/2011/11/30/southwest-us-bucks-antibiotic-use-trend.htm
http://pharma.about.com/b/2011/11/30/ama-calls-for-swift-action-on-drug-shortages.htm
http://pharma.about.com/b/2011/11/22/fujifilm-takes-bigger-role-in-biosimilar-development.htm
http://pharma.about.com/b/2011/11/07/xarelto-approved-for-stroke-prevention.htm
http://pharma.about.com/b/2011/04/17/gsk-puts-alli-and-other-otc-drugs-on-the-block.htm
http://pharma.about.com/b/2011/04/11/obesity-drug-back-in-play-following-positive-trial-results.htm
http://pharma.about.com/b/2011/04/28/managed-care-pharmacists-keep-ahead-of-the-curve.htm
http://pharma.about.com/b/2011/04/30/embryonic-stem-cell-research-allowed-to-proceed-again.htm
http://pharma.about.com/b/2011/04/30/pharmacy-researchers-drill-down-on-patient-adherence.htm
http://pharma.about.com/b/2011/01/23/pharma-ad-spending-down-in-2010.htm
http://pharma.about.com/b/2011/01/14/india-adds-barcode-requirement-on-pharma-exports.htm
http://pharma.about.com/b/2011/01/09/fda-requires-addition-to-clinical-trial-informed-consent-documents.htm
http://pharma.about.com/b/2011/01/26/phrma-gives-sotu-speech-a-thumbs-up.htm
http://pharma.about.com/b/2011/09/13/supreme-court-sets-date-to-hear-mayo-prometheus-patents-case.htm
http://pharma.about.com/b/2011/09/13/554.htm
http://pharma.about.com/b/2011/09/13/pres-obama-to-sign-patent-reform-law-sept-16.htm
http://pharma.about.com/b/2011/09/30/pharmaceutical-exec-blames-fda-inspections-for-drug-shortages.htm
http://pharma.about.com/b/2011/09/12/another-new-medical-use-for-botulinum-toxin.htm
http://pharma.about.com/b/2011/09/16/nih-to-facilitate-bench-to-bedside-license-agreements-for-start-up-companies.htm
http://pharma.about.com/b/2011/09/26/pfizer-expands-its-biomanufacturing-plant-in-ireland.htm
http://pharma.about.com/b/2011/09/10/atrial-fib-drugs-multaq-experience-may-make-it-harder-to-approve-xarelto.htm
http://pharma.about.com/b/2011/09/10/a-dozen-pharmas-make-payments-to-physicians-public.htm
http://pharma.about.com/b/2011/12/18/pfizer-plans-to-keep-lipitor-customers-despite-loss-of-patent.htm
http://pharma.about.com/b/2011/12/21/2011-top-medical-news-stories-about-drugs.htm
http://pharma.about.com/b/2011/12/01/clinicaltrials-gov-still-amazes.htm
http://pharma.about.com/b/2011/12/26/congress-abandons-internet-piracy-bill-favored-by-pharmas-for-now.htm
http://pharma.about.com/b/2011/12/26/fda-approved-hangover-remedy-ready-for-new-years.htm
http://pharma.about.com/b/2011/12/31/procolor-biotech-pursuing-biobetter-for-growth-hormone-deficiencies.htm
http://pharma.about.com/b/2011/12/31/wikileaks-cable-haunted-pfizer-in-2011.htm
http://pharma.about.com/b/2011/06/21/weighing-in-on-comparative-effectiveness-drug-trials.htm
http://pharma.about.com/b/2011/06/14/survey-most-americans-have-their-children-vaccinated-but-express-safety-concerns.htm
http://pharma.about.com/b/2011/06/08/dr-reddys-soon-to-be-a-household-name.htm
http://pharma.about.com/b/2011/06/27/researchers-keep-marketers-out-of-clinical-trial-process.htm
http://pharma.about.com/b/2011/06/13/wisc-otc-manufacturer-distributor-face-fda-injunction.htm
http://pharma.about.com/b/2011/03/25/oops-fda-new-drug-approvals-tally-excludes-biologics.htm
http://pharma.about.com/b/2011/03/27/human-gene-patents-in-limbo.htm
http://pharma.about.com/b/2011/03/07/collaborative-pharmas-and-union-workers-break-adversary-strereotypes.htm
http://pharma.about.com/b/2011/10/17/harvard-medical-school-to-apply-systems-approach-to-drug-discovery.htm
http://pharma.about.com/b/2011/10/24/infectious-disease-experts-analyze-physician-views-on-vaccines.htm
http://pharma.about.com/b/2011/10/26/analysis-of-flu-vaccines-finds-effectiveness-falls-short-of-claims.htm
http://pharma.about.com/b/2011/10/10/infectious-disease-experts-wanted-new-drugs-now-they-have-them.htm
http://pharma.about.com/b/2011/10/31/obama-takes-executive-action-on-drug-shortages.htm
http://pharma.about.com/b/2011/10/31/fda-tempers-viibryd-expectations-in-journal-article.htm
http://pharma.about.com/b/2011/07/07/european-austerity-budgets-target-pharmaceutical-pricing.htm
http://pharma.about.com/b/2010/11/19/pharmas-make-top-green-rankings.htm
http://pharma.about.com/b/2010/12/17/pharmas-eye-brazil.htm
http://pharma.about.com/b/2010/12/05/bare-truth-in-love-and-other-drugs.htm
http://pharma.about.com/b/2010/12/20/pharmas-tops-in-settlements-paid-to-government.htm
http://pharma.about.com/b/2010/12/14/patient-privacy-concerns-precede-smart-pills.htm
http://pharma.about.com/b/2010/12/06/wikileaked-cable-lists-pharmas-vital-to-national-security.htm
http://pharma.about.com/b/2010/12/10/noose-tightens-on-rogue-online-pharmacies.htm
http://pharma.about.com/b/2010/12/29/genetic-study-shows-how-50-year-old-drug-helps-people-with-diabetes.htm
http://pharma.about.com/b/2010/10/14/website-promotes-patient-adherance.htm
http://pharma.about.com/b/2010/10/14/combat-mad-scientist-myth.htm
http://pharma.about.com/b/2010/10/14/another-anti-obesity-hopeful-about-to-bite-the-dust.htm
http://pharma.about.com/b/2012/02/08/immunization-schedule-updates-for-children-and-adults-published.htm
http://pharma.about.com/b/2012/02/16/fda-counterfeit-avastin-found-in-three-states.htm
http://pharma.about.com/b/2012/02/16/informed-consent-documents-revised-for-clinical-trials.htm
http://pharma.about.com/b/2012/02/22/fda-to-review-aeroshot-an-inhaleable-caffeine.htm
http://pharma.about.com/b/2012/02/22/fda-panel-votes-20-2-to-approve-qnexa-for-weight-loss.htm
http://pharma.about.com/b/2012/02/22/pharma-employment-still-taking-hits.htm
http://pharma.about.com/b/2012/02/29/dallas-doctor-charged-with-largest-medicare-fraud-in-history.htm
http://pharma.about.com/b/2012/05/02/three-new-ms-drugs-could-reach-the-market-in-2012-13.htm
http://pharma.about.com/b/2012/05/14/lenalidomide-improved-outcomes-for-multiple-myeloma-after-stem-cell-transplants.htm
http://pharma.about.com/b/2012/05/01/antibiotic-approved-to-treat-and-prevent-plague.htm
http://pharma.about.com/b/2012/05/12/researchers-fool-opioid-receptors-into-strengthening-immune-system.htm
http://pharma.about.com/b/2012/05/03/whos-tops-in-pharma-ceo-salaries.htm
http://pharma.about.com/b/2012/04/02/phase-3-trial-tevas-laquinimod-reduces-progression-of-relapsing-ms.htm
http://pharma.about.com/b/2012/04/24/collaboration-or-just-good-timing.htm
http://pharma.about.com/b/2012/04/23/review-of-adverse-events-finds-little-risk-in-herpes-zoster-shingles-vaccine.htm
http://pharma.about.com/b/2012/04/30/many-reasons-for-gardasils-slow-sales.htm
http://pharma.about.com/b/2012/04/30/drugs-approved-for-pediatric-use.htm
http://pharma.about.com/b/2012/04/09/panel-recommends-full-weight-based-chemotherapy-for-obese-cancer-patients.htm
http://pharma.about.com/b/2012/04/16/fda-counterfeit-cancer-medicines-putting-patients-at-risk.htm
http://pharma.about.com/b/2012/04/06/researchers-vast-majority-of-preclinical-cancer-studies-not-reproducible.htm
http://pharma.about.com/b/2012/04/29/fda-to-co-sponsor-industry-cgmp-conference.htm
http://pharma.about.com/b/2012/01/23/pharma-whistleblower-story-gets-picked-up-by-film-producer.htm
http://pharma.about.com/b/2012/01/14/cdc-fatal-prescription-drug-overdose-rate-tripled-since-1990.htm
http://pharma.about.com/b/2012/01/11/national-academy-of-sciences-call-for-limited-use-of-chimpanzees-in-research.htm
http://pharma.about.com/b/2012/01/28/viibryd-and-bystolic-help-forest-labs-exceed-sales-projections.htm
http://pharma.about.com/b/2012/01/28/fda-approves-btgs-biologics-license-application-bla-for-voraxaze.htm
http://pharma.about.com/b/2012/01/13/fast-tracked-cancer-drug-implicated-in-brain-inflammation-in-3-patients.htm
http://pharma.about.com/b/2012/01/13/fda-cancer-drug-shortages-price-tags-encourage-counterfeits.htm
http://pharma.about.com/b/2012/01/13/dissecting-fdas-draft-guidance-on-mobile-medical-apps.htm
http://pharma.about.com/b/2012/01/09/fda-drug-approvals-up-in-2011.htm
http://pharma.about.com/b/2012/01/09/no-dissipation-of-controversy-over-hhs-decision-on-plan-b.htm
http://pharma.about.com/b/2012/01/09/novartis-recalls-some-popular-otc-drugs.htm
http://pharma.about.com/b/2012/01/09/study-newly-identified-compound-could-prevent-sudden-heat-stroke.htm
http://pharma.about.com/b/2012/01/10/fda-to-send-recommendations-on-biosimilar-user-fees-to-congress.htm
http://pharma.about.com/b/2012/03/18/fda-seeks-input-on-modernizing-clinical-trials-regs.htm
http://pharma.about.com/b/2012/03/18/takedas-new-diabetes-drug-reduces-hypoglycemia-risk-in-phase-2-trial.htm
http://pharma.about.com/b/2012/03/20/supreme-court-rules-prometheus-patents-law-of-nature-and-invalid.htm
http://pharma.about.com/b/2012/03/11/study-antipsychotic-haloperidol-raises-mortality-risk-in-nursing-homes.htm
http://pharma.about.com/b/2012/03/01/rare-disease-day-highlights-needs.htm
http://pharma.about.com/b/2012/03/12/protein-could-be-possible-target-for-obesity-drugs.htm
http://pharma.about.com/b/2012/03/12/microchips-inc-publishes-results-of-osteoporosis-trial.htm
http://pharma.about.com/b/2012/03/26/eli-lilly-to-introduce-a-dozen-plus-products-in-china.htm